Proteolysis, Cell Adhesion, Chemotaxis, and Invasiveness Are Regulated by the u-PA-u-PAR-PAI-1 System

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Thrombosis and Haemostasis

• Publication date

  1999-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-0037-1615846PMID 10605717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types

  1999cited by this paper
• Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells.

  1999cited by this paper
• Urokinase is required for T lymphocyte proliferation and activation in vitro.

  1999cited by this paper
• Urokinase Receptor (CD87) Regulates Leukocyte Recruitment via β2 Integrins In Vivo

  1998cited by this paper
• Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

  1998cited by this paper
• The urokinase‐type plasminogen activator system in cancer metastasis: A review

  1997cited by this paper
• A urokinase‐sensitive region of the human urokinase receptor is responsible for its chemotactic activity

  1997cited by this paper
• Cell-surface acceleration of urokinase-catalyzed receptor cleavage.

  1997cited by this paper
• Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes

  1997cited by this paper
• uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways?

  1997cited by this paper
• Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.

  1997cited by this paper
• Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.

  1996cited by this paper
• Chemokine receptors: Gateways to inflammation and infection

  1996cited by this paper
• Signal transduction and the u-PA/u-PAR system

  1996cited by this paper
• Genetic analysis of the plasminogen and coagulation system in mice.

  1996cited by this paper
• The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin

  1996cited by this paper
• Regulation of Integrin Function by the Urokinase Receptor

  1996cited by this paper
• Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells.

  1996cited by this paper
• Impaired migration in vitro of neutrophils from patients with paroxysmal nocturnal haemoglobinuria

  1996cited by this paper
• Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes.

  1996cited by this paper
• Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model.

  1996cited by this paper
• Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization.

  1996cited by this paper
• Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin αvβ5-directed Cell Migration*

  1996cited by this paper
• Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.

  1996cited by this paper
• Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals.

  1996cited by this paper
• Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

  1996cited by this paper
• Proteolytic cleavage of the urokinase receptor substitutes for the agonist‐induced chemotactic effect.

  1996cited by this paper
• The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin.

  1996cited by this paper
• The urokinase receptor is a major vitronectin-binding protein on endothelial cells.

  1996cited by this paper
• Impaired wound healing in mice with a disrupted plasminogen gene

  1996cited by this paper
• alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)- dependent internalization of the urokinase receptor

  1995cited by this paper
• The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion

  1995cited by this paper
• Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression.

  1995cited by this paper
• Urokinase plasminogen activator receptor, beta 2-integrins, and Src- kinases within a single receptor complex of human monocytes

  1995cited by this paper
• Identification of the urokinase receptor as an adhesion receptor for vitronectin.

  1994cited by this paper
• A cleaved form of the receptor for urokinase‐type plasminogen activator in invasive transplanted human and murine tumors

  1994cited by this paper
• Structure—function relationships in the receptor for urokinase‐type plasminogen activator Comparison to other members of the Ly‐6 family and snake venom α‐neurotoxins

  1994cited by this paper
• Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins.

  1994cited by this paper
• Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells

  1994cited by this paper
• Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy.

  1994cited by this paper
• Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes.

  1994cited by this paper
• The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.

  1994cited by this paper
• The urokinase receptor: Structure, regulation and inhibitor-mediated internalization

  1994cited by this paper
• Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?

  1994cited by this paper
• Cell-surface plasminogen activation causes a retraction of in vitro cultured human umbilical vein endothelial cell monolayer.

  1994cited by this paper
• The urokinase receptor is required for human monocyte chemotaxis in vitro.

  1994cited by this paper
• Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): a nonplasmin fibrinolytic pathway.

  1993cited by this paper
• Upregulation of urokinase receptor expression on migrating endothelial cells

  1993cited by this paper
• Distribution and lateral mobility of the urokinase-receptor complex at the cell surface.

  1993cited by this paper
• Prevention of metastasis by inhibition of the urokinase receptor.

  1993cited by this paper
• Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors.

  1993cited by this paper
• Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes.

  1992cited by this paper
• Urokinase‐type plasminogen activator mediates basic fibroblast growth factor‐induced bovine endothelial cell migration independent of its proteolytic activity

  1992cited by this paper
• Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.

  1992cited by this paper
• Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse.

  1991cited by this paper
• Urokinase‐receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells.

  1991cited by this paper
• An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines.

  1991cited by this paper
• The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

  1990cited by this paper
• Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome.

  1990cited by this paper
• Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells.

  1990cited by this paper
• Receptor‐mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI‐1.

  1990cited by this paper
• Plasminogen activator inhibitors: hormonally regulated serpins.

  1990cited by this paper
• Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.

  1990cited by this paper
• Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self- regulating system

  1990cited by this paper
• Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

  1989cited by this paper
• Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate

  1989cited by this paper
• Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.

  1989cited by this paper
• Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin

  1988cited by this paper
• Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.

  1988cited by this paper
• Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells.

  1988cited by this paper
• In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase

  1988cited by this paper
• Association between alveolar macrophage plasminogen activator activity and indices of lung function in young cigarette smokers.

  1988cited by this paper
• Surface Receptors for Urokinase Plasminogen Activator

  1988cited by this paper
• Receptor Mediated Binding of the Fibrinolytic Components, Plasminogen and Urokinase, to Peripheral Blood Cells

  1987cited by this paper
• Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils.

  1987cited by this paper
• Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells

  1987cited by this paper
• Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo.

  1987cited by this paper
• Inhibition of tumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin I.

  1986cited by this paper
• The importance of the Mac-1, LFA-1 glycoprotein family in monocyte and granulocyte adherence, chemotaxis, and migration into inflammatory sites: insights from an experiment of nature.

  1986cited by this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cited by this paper
• Antibodies to plasminogen activator inhibit human tumor metastasis.

  1983cited by this paper

• Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs

  2023cites this paper
• Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy

  2021cites this paper
• The cAMP-ERK1/2 signaling pathway regulates urokinase-type plasminogen activator-induced bovine granulosa cell proliferation.

  2020cites this paper
• Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma

  2020influential citation
• Urinary albumin excretion and progression of renal disease with impaired fi brinolytic activity in type 2 diabetes mellitus

  2020cites this paper
• Plasminogen repairs abnormal pain perception through improving sensory function recovery and regeneration of peripheral small nerve fiber in db/db mice

  2019cites this paper
• Lysophosphatidic acid increases in vitro maturation efficiency via uPA-uPAR signaling pathway in cumulus cells.

  2018cites this paper
• Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors

  2017cites this paper
• The Dual Regulatory Role of MiR-181a in Breast Cancer

  2017cites this paper
• Clinical Significance of CD87 Expression in Acute Myeloblastic Leukemia.

  2016cites this paper
• Clinical Significance of CD 87 Expression in Acute Myeloblastic Leukemia

  2016cites this paper
• Plasminogen is a critical regulator of cutaneous wound healing

  2016cites this paper
• Vascular endothelial cell Toll-like receptor pathways in sepsis

  2015cites this paper
• Statins Increase Plasminogen Activator Inhibitor Type 1 Gene Transcription through a Pregnane X Receptor Regulated Element

  2015cites this paper
• Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus

  2015cites this paper
• An Ultra-Sensitive Immunoassay for Quantifying Biomarkers in Breast Tumor Tissue

  2014cites this paper
• uPA‐uPAR molecular complex is involved in cell signaling during neuronal migration and neuritogenesis

  2014cites this paper
• Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis

  2014cites this paper
• Urokinase-type plasminogen activator receptor as a predictor of poor outcome in patients with systemic inflammatory response syndrome

  2013cites this paper
• Role of Urokinase Receptor in Tumor Progression and Development

  2013cites this paper
• Transplantation of modified human adipose derived stromal cells expressing VEGF165 results in more efficient angiogenic response in ischemic skeletal muscle

  2013cites this paper
• Humoral innate immune response and disease

  2012cites this paper
• Proteins and carbohydrates in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy

  2012cites this paper
• Utility of serum and urine uPAR levels for diagnosis of breast cancer.

  2012cites this paper
• Interleukin Enhancer-Binding Factor 3 Promotes Breast Tumor Progression by Regulating Sustained Urokinase-Type Plasminogen Activator Expression

  2012cites this paper
• Expression of protein kinase C α and the MZF-1 and Elk-1 transcription factors in human breast cancer cells.

  2012cites this paper
• SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes.

  2012cites this paper
• Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-β3.

  2011cites this paper
• Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening

  2011cites this paper
• Impaired MicroRNA Processing Facilitates Breast Cancer Cell Invasion by Upregulating Urokinase-Type Plasminogen Activator Expression.

  2011cites this paper
• Effect of alpha3beta1 and alphavbeta3 integrin glycosylation on interaction of melanoma cells with vitronectin.

  2010cites this paper
• Curcumin Facilitates Fibrinolysis and Cellular Migration during Wound Healing by Modulating Urokinase Plasminogen Activator Expression

  2010cites this paper
• Prostate cancer : Aspects of screening and prognostic factors

  2010cites this paper
• Novel protein interactors of urokinase-type plasminogen activator receptor.

  2010cites this paper
• NFκB-dependent regulation of urokinase plasminogen activator by proanthocyanidin-rich grape seed extract: effect on invasion by prostate cancer cells

  2010cites this paper
• Interaction between urokinase receptor and heat shock protein MRJ enhances cell adhesion.

  2010cites this paper
• Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin®) eye drops against corneal neovascularization

  2009cites this paper
• Coagulation Disorders in Sepsis

  2009cites this paper
• Clinical proteomics in breast cancer: a review

  2009cites this paper
• Podstawy terapii antyangiogennej u chorych na nowotwory

  2009cites this paper
• The relationship between urokinase plasminogen activator/plasminogen activator inhibitor type-1 expression in myoma/myometrium and mechanism of uterine artery occlusion by laparoscopy for uterine myoma treatment

  2009cites this paper
• Management of sepsis : the PIRO approach

  2009cites this paper
• Role of plasminogen activator-plasmin system in tumor angiogenesis

  2009cites this paper
• Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling.

  2009cites this paper
• Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis

  2009cites this paper
• Detection of Breast Cancer by Surface-enhanced Laser Desorption/Ionization Time-of-flight Mass Spectrometry Tissue and Serum Protein Profiling

  2009cites this paper
• Future Target Molecules in Antiglaucoma Therapy: TGF-β May Have a Role to Play

  2009cites this paper
• The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics.

  2009cites this paper
• uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer

  2008cites this paper
• Hemoglobinuria paroxística nocturna

  2008cites this paper
• The role of urokinase-type plasminogen activator (uPA) and transforming growth factor beta 1 (TGFbeta1) in muscle regeneration.

  2008cites this paper
• Unequal tissue expression of proteins from the PA/PAI system, myoma necrosis, and uterus survival after uterine artery occlusion

  2008cites this paper
• The effect of topical bevacizumab on corneal neovascularization.

  2008cites this paper
• Caracterisation de la structure généalogique d'un échantillon familial d'individus asthmatiques originaires du Saguenay-Lac-St-Jean

  2008cites this paper
• Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C.

  2008cites this paper
• Matrix metalloproteinase-9 Inhibition Down-Regulates Radiation-Induced Nuclear Factor-κB Activity Leading to Apoptosis in Breast Tumors

  2008cites this paper
• Inflammation, endothelium, and coagulation in sepsis

  2008cites this paper
• [Paroxysmal nocturnal hemoglobinuria].

  2008cites this paper
• The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization.

  2008cites this paper
• Fibrinolysis: the key to new pathogenetic mechanisms.

  2008cites this paper
• Cell Surface-Bound Plasminogen Regulates Hepatocyte Proliferation Through a uPA-Dependent Mechanism

  2007cites this paper
• Elevated urokinase‐specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator

  2007cites this paper
• Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle.

  2007cites this paper
• Reduced transthyretin expression in sera of lung cancer

  2007cites this paper
• A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells.

  2007cites this paper
• Inhibition of Histone Deacetylase Activity Promotes Invasion of Human Cancer Cells through Activation of Urokinase Plasminogen Activator*

  2007cites this paper
• Pancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice.

  2006cites this paper
• Is the Urokinase-type Plasminogen Activator System a Reliable Prognostic Factor in Gastric Cancer?

  2006cites this paper
• Expression of PEA3 and Lack of Correlation Between PEA3 and HER-2/neu Expression in Breast Cancer

  2006cites this paper
• RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth.

  2006cites this paper
• Promotion of corneal epithelial wound healing in vitro and in vivo by annexin A5.

  2006cites this paper
• Mathematical Modelling of Proteolysis and Cancer Cell Invasion of Tissue

  2006cites this paper
• Hypoxia Regulates Cross-talk between Syk and Lck Leading to Breast Cancer Progression and Angiogenesis*

  2006cites this paper
• Interleukin-1α enhances the aggressive behavior of pancreatic cancer cells by regulating the α6β1-integrin and urokinase plasminogen activator receptor expression

  2006cites this paper
• Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.

  2006cites this paper
• Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model

  2006cites this paper
• Urokinase-type plasminogen activator receptor plays a role in neutrophil migration during lipopolysaccharide-induced peritoneal inflammation but not during Escherichia coli-induced peritonitis.

  2006cites this paper
• Defining the mechanism and functional consequences of PAI-2-mediated uPA/uPAR endocytosis

  2006influential citation
• The role of hepatic type 1 plasminogen activator inhibitor (PAI‐1) during murine hemorrhagic shock

  2005cites this paper
• Plasminogen Activator Inhibitor-1: The Expression, Biological Functions, and Effects on Tumorigenesis and Tumor Cell Adhesion and Migration

  2005cites this paper
• Urinary trypsin inhibitor suppresses surgical stress-facilitated lung metastasis of murine colon 26-L5 carcinoma cells.

  2005cites this paper
• Classification of cancer types by measuring variants of host response proteins using SELDI serum assays

  2005cites this paper
• Mathematical modelling of cancer cell invasion of tissue

  2005cites this paper
• The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1).

  2005cites this paper
• Rôle des protéinases et de leurs inhibiteurs dans les formes associées à une néovascularisation anormale sous-rétinienne. Caractérisation par l’étude de modèles animaux transgéniques et développements thérapeutiques.

  2005cites this paper
• Urokinase-induced smooth muscle cell migration requires PI3-K and Akt activation.

  2005cites this paper
• Role of Proteases in Pancreatic Carcinoma

  2005cites this paper
• Alpha-enolase plasminogen receptor in myogenesis.

  2005cites this paper
• Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation.

  2005cites this paper
• Evaluation of cerebrospinal fluid uPA, PAI-1, and soluble uPAR levels in HIV-infected patients.

  2005cites this paper
• Signaling Mechanisms Responsible for Lysophosphatidic Acid-induced Urokinase Plasminogen Activator Expression in Ovarian Cancer Cells*

  2005cites this paper
• Ascites induces modulation of α6β1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma

  2005cites this paper
• Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?

  2005cites this paper
• Clinical significance of urokinase‐type plasminogen activator receptor (uPAR) expression in cancer

  2004cites this paper
• CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review

  2004cites this paper
• Activation of tissue plasminogen activator gene transcription by Neovastat, a multifunctional antiangiogenic agent.

  2004cites this paper
• Contribution of the hemostatic system to angiogenesis in cancer.

  2004cites this paper
• Interfering with hemostatic system components: possible new approaches to antiangiogenic therapy.

  2004cites this paper
• Patogenia de la trombosis asociada a enfermedades neoplásicas: implicaciones terapéuticas

  2004cites this paper
• A central role for plasminogen in the inflammatory response to biomaterials

  2004cites this paper